Abiopharma

🔍 Rackliffe Philip (Executive)

Company: GE HealthCare Technologies Inc. (GEHC)

Report Date: 2025-09-01

Detailed Transactions and Holdings:

• Sold 165 shares of Common Stock, par value $0.01 per share at $73.73 per share (Direct)
  Date: 2025-09-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 17,308.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 134 shares of Common Stock, par value $0.01 per share at $73.73 per share (Direct)
  Date: 2025-09-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 17,174.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 204 shares of Common Stock, par value $0.01 per share at $73.73 per share (Direct)
  Date: 2025-09-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 16,970.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,388 shares of Common Stock, par value $0.01 per share at $73.73 per share (Direct)
  Date: 2025-09-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 15,582.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.